Sio Gene Therapies Performance
| SIOXDelisted Stock | USD 0.40 0.01 2.56% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Sio Gene are completely uncorrelated. Sio Gene Therapies right now has a risk of 0.0%. Please validate Sio Gene daily balance of power , to decide if Sio Gene will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sio Gene Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Sio Gene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 120.2 M | |
| Total Cashflows From Investing Activities | 3.6 M |
Sio |
Sio Gene Relative Risk vs. Return Landscape
If you would invest 40.00 in Sio Gene Therapies on September 4, 2024 and sell it today you would earn a total of 0.00 from holding Sio Gene Therapies or generate 0.0% return on investment over 90 days. Sio Gene Therapies is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Sio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sio Gene Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sio Gene's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sio Gene Therapies, and traders can use it to determine the average amount a Sio Gene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SIOX |
Based on monthly moving average Sio Gene is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sio Gene by adding Sio Gene to a well-diversified portfolio.
Sio Gene Fundamentals Growth
Sio Stock prices reflect investors' perceptions of the future prospects and financial health of Sio Gene, and Sio Gene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sio Stock performance.
| Return On Equity | -0.47 | |||
| Return On Asset | -0.24 | |||
| Current Valuation | (23.36 M) | |||
| Shares Outstanding | 73.98 M | |||
| Price To Book | 0.54 X | |||
| EBITDA | (70.94 M) | |||
| Cash And Equivalents | 54.77 M | |||
| Cash Per Share | 0.74 X | |||
| Total Debt | 2.36 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.61 X | |||
| Cash Flow From Operations | (60.35 M) | |||
| Earnings Per Share | (0.38) X | |||
| Total Asset | 75.08 M | |||
About Sio Gene Performance
Evaluating Sio Gene's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Sio Gene has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sio Gene has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York. Sio Gene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.Things to note about Sio Gene Therapies performance evaluation
Checking the ongoing alerts about Sio Gene for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sio Gene Therapies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sio Gene Therapies is not yet fully synchronised with the market data | |
| Sio Gene Therapies has some characteristics of a very speculative penny stock | |
| Sio Gene Therapies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (71.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Sio Gene Therapies currently holds about 54.77 M in cash with (60.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Sio Gene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sio Gene's stock is overvalued or undervalued compared to its peers.
- Examining Sio Gene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sio Gene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sio Gene's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sio Gene's stock. These opinions can provide insight into Sio Gene's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |